301333.SZShenzhen
R&G PharmaStudies Co., Ltd.
¥46.86
ListedAug 2, 2022
SectorHealthcare
IndustryBiotechnology
CountryChina
Employees2645
State-| CityBeijing| AddressNorth Tower| Phone-
R&G PharmaStudies Co., Ltd. operates as a clinical trial outsourcing service provider in China and internationally. It offers drug clinical research and development integrated services. The company's services include clinical trial operation, clinical trial site management, biological sample testing, data management and statistical analysis, clinical trial consulting, and clinical pharmacology services. It serves pharmaceutical and medical device companies, and scientific research institutions. The company was founded in 2008 and is headquartered in Beijing, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
36.2
?
Div. Rate
¥0.16
?
Div. Yield
0.32%
?
Payout Ratio
11.43%
?
Max Consec. Div. Years
3 years
?
Longest Consec. Div.
3 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.22
?
Div. Growth Rate
0.00%
?
Score
73

Dividend History

Historical dividend payments by ex-dividend date.

Jul 8, 2025
¥ 0.1600
Jul 5, 2024
¥ 0.2000
Jun 29, 2023
¥ 0.2500

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!